Between now and June 26, representatives with the Vote Yes On 788 campaign will be traveling statewide and meeting face-to-face with voters. NORML will also be focusing its resources in the coming months to support these campaign efforts.
Category: Medical Cannabis
Oklahoma voters will decide this June on State Question 788 — a statewide ballot measure legalizing the use, cultivation, and distribution of medical cannabis to qualified patients.
Today, sixty-six members of Congress representing both Republicans and Democrats sent a letter to Speaker Ryan, Senate Majority Leader McConnell, Leader Pelosi, and Leader Schumer urging them to maintain the federal protections for the 46 states that have implemented some form of medical cannabis programs throughout the country.
In a new poll of US service veterans conducted by The American Legion and presented today on Capitol Hill, one in five veterans self-reported using marijuana to alleviate a medical or physical condition.
Despite the growing body of scientific evidence showing that cannabis access is associated with reductions in opioid use and mortality, the Chairman of the White House’s Commission on Combating Drug Addiction and the Opioid Crisis today called upon the President to reject any efforts to acknowledge marijuana’s promising role in mitigating opioid abuse and dependency.
Protections for the medical marijuana markets that are now legal in 30 states are set to expire on December 8th. After that, over 2 million registered patients’ continued access to their medication will rely on the prohibitionist whims of Attorney General Jeff Sessions, who has been lobbying aggressively for the ability to use the full force of the Justice Department to interfere with their operations.
Adults with a history of cannabis use are less likely to suffer from non-alcoholic fatty liver disease (NAFLD) than are those who have not used the substance, according to data published online in the journal PLoS One. “Active marijuana use provided a protective effect against NAFLD independent of known metabolic risk factors,” authors determined. “[W]e conclude that current marijuana use may favorably impact the pathogenesis of NAFLD in US adults.”
Retail cannabis distribution in Colorado is associated with a reduction in opioid-related mortality, according to data published online ahead of print in The American Journal of Public Health. Authors reported: “Colorado’s legalization of recreational cannabis sales and use resulted in a 0.7 deaths per month reduction in opioid-related deaths. This reduction represents a reversal of the upward trend in opioid-related deaths in Colorado.”